Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10287386 | 0.96 | ACHE (0.37) | ACHEUGT2B17 | |
| SCHEMBL10286101 | 0.89 | ACHE (0.34) | ACHEUGT2B17 | |
| SCHEMBL10286128 | 0.83 | UGT2B17 (0.41) | ACHEUGT2B17 | |
| SCHEMBL10286086 | 0.82 | UGT2B17 (0.36) | ACHEUGT2B17 | |
| SCHEMBL10286099 | 0.81 | ACHE (0.35) | ACHEUGT2B17 | |
| SCHEMBL10286106 | 0.80 | ACHE (0.37) | ACHEUGT2B17 | |
| SCHEMBL10286082 | 0.79 | ACHE (0.42) | ACHEUGT2B17 | |
| SCHEMBL10286103 | 0.79 | ACHE (0.39) | ACHEUGT2B17 | |
| SCHEMBL10287403 | 0.79 | UGT2B17 (0.45) | ACHEUGT2B17 | |
| SCHEMBL10286112 | 0.78 | ACHE (0.34) | ACHEUGT2B17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130102631-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | SYNGENTA CROP PROTECTION LLC (US) | 2013-04-25 | — | — | US | disclosed |
| WO-2012001040-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102631-A1 | NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES | MSR1, DDT, MPO | ACHE 660/4885UGT2B17 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.